Varian, a Siemens Healthineers company, has received 510(k) clearance from the U.S. FDA for the TrueBeam and Edge radiotherapy systems featuring the HyperSight imaging solution.
At this year’s ECR in Vienna, Philips introduced the Philips CT 5300 system equipped with advanced AI capabilities designed to be used for diagnosis, interventional procedures and screening. This flexible CT system in reases diagnostic confidence, streamlines workflow efficiency, and maximizes system up-time, helping to improve patient outcomes and department productivity.
Following the recent CE approval of the Solia S lead (1) for Left Bundle Branch Area Pacing (LBBAP), BIOTRONIK now provides the world’s first and only complete CSP system, fully CE-approved for LBBAP. (2)
Aston University has hosted an event to celebrate the launch of SPARK The Midlands www.sparkthemidlands.co.uk, a network which aims to bridge the gap between medical research discoveries of novel therapeutics, medical devices and diagnostics, and real-world clinical use.
An initiative with the aim of building stronger relationships between the NHS and industry was recently hosted and organised by the Imperial College Healthcare NHS Trust, in partnership with the Shelford Group and the Association of British HealthTech Industries (ABHI).
Affluent Medical, a French clinical-phase MedTech company specializing in the international development and industrialization of innovative medical prostheses, has carried out a successful first-in-human implantation of the minimally invasive medical device Artus for the treatment of urinary incontinence as part of the European pilot study ‘Dry’.
Ultrahuman, a pioneer in wearable tech, has raised $35 million in equity and debt investment. The series B funding round saw participation from venture capital firms Blume, Steadview, Nexus, Alpha Wave and Zomato founder Deepinder Goyal. Ultrahuman will use the funds to build more manufacturing capacity and expand research in the health tracking space.
An innovative project using artificial intelligence (AI) to personalise therapies for patients with cardiovascular disease has begun following a meeting in February in Utrecht, the Netherlands.
Researchers in France have embarked on a four-year project to test the new non-invasive technique, that could help surgeons quickly and accurately assess patients for potentially life-changing complications after neck surgery. The research could have global relevance.
WillowWood Global, a leading designer, manufacturer, and distributor of prosthtic products, has acquired Xtremity. The transaction builds on WillowWood’s growing strength in custom solutions which includes central fabrication, design liners, and now fully adjustable prosthetic sockets.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.